Skip to main content

Correction to: Efficacy of Ronopterin (VAS203) in Patients with Moderate and Severe Traumatic Brain Injury (NOSTRA phase III trial): study protocol of a confirmatory, placebocontrolled, randomised, double blind, multi-centre study

The Original Article was published on 14 January 2020

Correction to: Trials (2020) 21:80

https://doi.org/10.1186/s13063-019-3965-4

After publication of our article [1] the authors have notified us that one of the names has been incorrectly spelled.

  • Original name spelling:

    Charlotte Flühe

  • Correct name spelling:

    Charlotte Flüh

The original article has been corrected.

Reference

  1. Tegtmeier, et al. Efficacy of Ronopterin (VAS203) in Patients with Moderate and Severe Traumatic Brain Injury (NOSTRA phase III trial): study protocol of a confirmatory, placebocontrolled, randomised, double blind, multi-centre study. Trials. 2020;21:80. https://doi.org/10.1186/s13063-019-3965-4.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Reinhard Schinzel.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tegtmeier, F., Schinzel, R., Beer, R. et al. Correction to: Efficacy of Ronopterin (VAS203) in Patients with Moderate and Severe Traumatic Brain Injury (NOSTRA phase III trial): study protocol of a confirmatory, placebocontrolled, randomised, double blind, multi-centre study. Trials 21, 172 (2020). https://doi.org/10.1186/s13063-020-4107-8

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13063-020-4107-8